(Press-News.org) WASHINGTON—A new expert opinion document jointly released by the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Cardiovascular Computed Tomography (SCCT) presents a comprehensive framework for using coronary computed tomography angiography (CCTA) to guide percutaneous coronary intervention (PCI).
Published in JSCAI, “Coronary Computed Tomography Angiography to Guide Percutaneous Coronary Intervention: Expert Opinion from a SCAI/SCCT Roundtable” was developed through an October 2024 multidisciplinary roundtable, reflecting the complexity and collaborative nature of this evolving field. It was unveiled at a joint SCAI/SCCT symposium during the SCAI 2025 Scientific Sessions in Washington, DC.
“Many patients already undergo coronary CT as part of their workup. Our goal is to use that existing data to plan procedures more intelligently, reduce complications, and deliver more precise care,” said Yader Sandoval, MD, FSCAl, Chair of the roundtable and interventional cardiologist at Minneapolis Heart Institute. “This was more than just a conversation—it was a convergence of specialties. We had imagers who’ve read hundreds of thousands of scans, and interventionalists who do complex PCI every day, sitting side by side. And the goal was singular: improve outcomes by leveraging the CT scans we’re already performing.”
The document reflects the collective insights of leaders in cardiac imaging, interventional cardiology, and clinical trial design to address an emerging frontier: how to apply CT in a practical, step-by-step way to improve PCI outcomes. They sought to address a critical gap in practice: while coronary CT is routinely used to evaluate stable chest pain and assess coronary anatomy, its use in PCI preprocedural planning has remained underutilized. With expanding evidence of benefits that include the potential for reduced procedure time and radiation exposure, clinical interest has been growing, and the need for a practical, clinician-driven roadmap was clear.
“This wasn’t just an academic exercise—it was practical and forward-looking,” said Carlos Collet, MD, PhD, interventional cardiologist at OLV Clinic in Aalst, Belgium, and contributing author. “We discussed real-world applications: How do I look at a CT and know the plaque morphology? How do I estimate vessel size or predict wire path through a complex occlusion? This document translates those answers into step-by-step guidance.”
A major theme throughout the roundtable was bridging the gap between imaging and intervention. Unlike traditional diagnostic coronary CT, which may be interpreted by imagers alone, CT-guided PCI requires collaboration between specialists to fully harness both anatomic and physiologic data.
Jonathon Leipsic, MD, Co-Chair of the roundtable and radiologist at St. Paul’s Hospital in Vancouver, British Columbia, emphasized this interdisciplinary approach. “CT has long been foundational to planning structural heart interventions, where collaboration is baked into the workflow,” he said. “Now we’re applying that same philosophy to coronary disease. This document outlines current evidence and future opportunities, and importantly, it helps democratize the field. You don’t have to be a CT expert to start using these tools. We’re giving people a guide to get on the escalator—wherever they are—and move upward.”
In addition to detailed recommendations on image acquisition and interpretation, the document outlines the role of CT-derived fractional flow reserve (FFRCT) and virtual PCI modeling. These tools allow clinicians not only to evaluate anatomical stenosis, but also to predict the physiologic benefit of an intervention before it occurs. The consensus also delves into case selection, triage, lesion classification, equipment planning, and procedural strategy.
“The reason I’m so excited about this document is how practical it is,” said Emmanouil S. Brilakis, MD, PhD, FSCAI, interventional cardiologist at Minneapolis Heart Institute. “Interventionalists want a clear roadmap—how do I go from opening a CT to knowing what stent to use? This document walks through that process. And it’s not just about what’s possible—it’s also candid about what’s needed, like better software, more training, and reimbursement policies that match the value of the approach.”
The authors stressed the importance of education and collaboration in ensuring broader adoption. Training remains a key hurdle—many interventional cardiologists have limited exposure to cardiac CT interpretation. To address this, the roundtable emphasized the need for ongoing education, hands-on workshops, and software platforms tailored for proceduralists.
“We can’t move the field forward unless we train the next generation of interventionalists to see CT as a tool in their hands. That’s why we built this document to be a foundation for future programs—whether that’s an in-lab training module or a fellowship curriculum,” said Dr. Sandoval.
New clinical evidence is expected to reinforce the guidance provided. Trials like the P4 Study, which involves global participation, will add randomized data supporting CT-guided PCI in complex lesions. As this data emerges, the authors said they expect the field to evolve rapidly—and for CT to become a routine part of the planning of coronary interventions, as it already is in structural heart procedures.
The collaboration between SCAI and SCCT reflects growing recognition that planning coronary interventions requires both anatomic and physiologic insight. CT is well-positioned to offer both—and to do so noninvasively, before the patient ever enters the cath lab.
“This is a defining moment for interventional cardiology,” said Dr. Leipsic. “We know we can improve patient outcomes by planning better. CT helps us do that. Now we have a playbook.”
The roundtable was supported through an unrestricted educational grant from Shockwave Medical, Inc.
DOI: 10.1016/j.jscai.2025.103664
About Society for Cardiovascular Angiography & Interventions (SCAI)
The Society for Cardiovascular Angiography & Interventions, established in 1978, stands as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care. For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 5,000 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease. For more information, visit https://scai.org/.
For more information about the SCAI 2025 Scientific Sessions, visit https://scai.org/scai-2025-scientific-sessions. Follow @SCAI on X for the latest heart health news and use #SCAI2025 to follow the latest discussions.
About the Society of Cardiovascular Computed Tomography
Founded in 2005, the Society of Cardiovascular Computed Tomography (SCCT) is the international professional society devoted to improving health outcomes through effective use of cardiovascular computed tomography (CCT). SCCT is a community of physicians, scientists and technologists from over 85 countries advocating for access, research, education and clinical excellence in the use of CCT. For more information, please visit https://scct.org.
END
With CCTA poised to transform PCI planning, SCAI/SCCT publish expert opinion document
2025-05-01
ELSE PRESS RELEASES FROM THIS DATE:
GLP-1 studies add to growing body of evidence demonstrating significant benefit on cardiovascular outcomes
2025-05-01
Washington, D.C. – May 1, 2025 – New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of medications used to treat type 2 diabetes, play a significant role in improving cardiovascular outcomes like heart failure (HF), acute myocardial infarction (AMI), peripheral artery disease (PAD), and ST-elevation myocardial infarction (STEMI). The data were presented today at the Society for Cardiovascular Angiography & Interventions ...
Alarming rise in cardiovascular deaths for those with obesity disproportionately impacting minorities and women
2025-05-01
Washington, D.C. – May 1, 2025 – New data highlights juxtaposing trends in serious obesity-related cardiovascular events. A recent study details the obesity paradox in patients with critical limb ischemia (CLI), demonstrating lower mortality in patients with obesity by 50% compared to non-obese patients. Whereas separate data suggests there is a rising mortality rate of almost four-fold in premature cardiac arrest and acute myocardial infarction (AMI) patients with obesity, specifically in racial minorities and rural communities. The data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 ...
Rhythmically trained sea lion returns for an encore—and performs as well as humans
2025-05-01
Santa Cruz, Calif.—Animal research on biomusicality, which looks at whether different species are capable of behaving in ways that show they recognize aspects of music, including rhythm and beat, remains a tantalizing field at the intersection of biology and psychology. Now, the highly trained California sea lion at UC Santa Cruz who achieved global fame for her ability to bob her head to a beat is finally back: starring in a new study that shows her rhythm is just as precise—if not better—than humans.
Ronan first shimmied onto the world stage in 2013, when researchers at the university’s Long Marine Laboratory reported that, not only ...
Study of facial bacteria could lead to probiotics that promote healthy skin
2025-05-01
CAMBRIDGE, MA -- The composition of bacterial populations living on our faces plays a significant role in the development of acne and other skin conditions such as eczema. Two species of bacteria predominate in most people, but how they interact with each other, and how those interactions may contribute to disease, has been difficult to study.
MIT researchers have now revealed the dynamics of those interactions in more detail than previously possible, shedding light on when and how new bacterial strains emerge on the skin of the face. Their findings could help guide the development of new treatments for ...
Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer
2025-05-01
About The Study: The findings of this study suggest a narrowing of racial and ethnic disparities in receipt of ERBB2 (formerly HER2 or HER2/neu)-targeted therapies over time among older Medicare beneficiaries with ERBB2-positive breast cancer. Future research is needed to understand the practices that contributed to the narrowing of racial and ethnic disparities and to develop implementation strategies to effectively improve the quality and equity of breast cancer care.
Corresponding Author: To contact the corresponding author, Utibe R. Essien, MD, MPH, email uessien@mednet.ucla.edu.
To access the embargoed ...
Designer microbe shows promise for reducing mercury absorption from seafood
2025-05-01
Key takeaways
· UCLA and UCSD scientists inserted DNA-encoding methylmercury detoxification enzymes into the genome of an abundant human gut bacterium. The engineered bacterium detoxified methylmercury in the gut of mice and dramatically reduced the amount that reached other tissues, such as the brain and liver.
· Mice given an oral probiotic containing the engineered microbe and fed a diet high in bluefin tuna had much lower methylmercury levels than expected, suggesting that a probiotic might eventually make it safer for people to consume fish.
· Researchers performed ...
Sex- and race-specific prevalence of hearing loss across the adult lifespan and associated factors
2025-05-01
About The Study: The prevalence and degree of hearing loss were highest among white male individuals and lowest among Black female individuals in this cohort study of 1,787 adults. Some factors associated with hearing loss, including noise exposure, differed across sex-specific and race-specific groups. Hearing loss is an important public health concern that could be addressed through tailored interventions to reduce its risk across populations.
Corresponding Author: To contact the corresponding author, Lauren K. Dillard, PhD, AuD, email dillalau@musc.edu.
To ...
Ptero firma: Footprints pinpoint when ancient flying reptiles conquered the ground
2025-05-01
Fossils of footprints over 160 million years old have helped palaeontologists at the University of Leicester to narrow down when pterosaurs adapted to live on the ground.
These awe-inspiring flying reptiles of the Mesozoic era are often imagined soaring over the heads of dinosaurs. But new research shows that some of these ancient creatures were just as comfortable walking on the ground.
In a groundbreaking new study published today in Current Biology (1 May), scientists at the University of Leicester have ...
New research from Mass General Brigham guides treatment regimen for aggressive blood cancer
2025-05-01
Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas
Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontline therapies. A team of Mass General Brigham researchers found that patients with these lymphomas had improved survival rates when treated with small molecule inhibitors as second-line therapy, followed by epigenetic modifiers as third-line therapy. Results of the study are published in the British Journal of Haematology.
“Our robust ...
USC team develops a powerful new analytical tool to advance CAR T cell therapy research
2025-05-01
A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen receptor (CAR) T cells, including how they evolve during manufacturing and which ones are most effective at killing cancer. Using the platform, which leverages a laser-based technology known as spectral flow cytometry, researchers have already found one key insight: CAR T cells are better equipped to fight cancer after a shorter five-day expansion process than at the 10-day mark.
The study was just published in the 25th anniversary special issue of Molecular Therapy, the flagship journal of the American Society of Gene & Cell Therapy.
CAR ...